Barbara A. Belli
11Patents
9h-index
14Co-inventors
65Inventor score
Filing activity: Oct 30, 1996 → Jan 18, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5843723A | Alphavirus vector constructs | Emerging Cross-Sectional Technologies | 162 | Expired |
| US7811812B2 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 38 | Expired |
| US7977091B2 | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 36 | Active |
| US6391632B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 28 | Expired |
| US6451592B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 19 | Expired |
| US8357690B2 | Methods of treatment using combination therapy | Human Necessities | 19 | Active |
| US7744900B2 | Enhancement of the immune response for vaccine and gene therapy applications | Human Necessities | 15 | Active |
| US6465634B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 12 | Expired |
| US7572628B2 | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6458560B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 9 | Expired |
| US8836218B2 | Methods of treatment using combination therapy | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.